CN

The Guangzhou Sino-Israel Biotech Investment Fund (GIBF)

SINO-ISRAEL BIO-INDUSTRY INVESTMENT FUND

The Guangzhou Sino-Israel Biotech Investment Fund (GIBF) is established in March 2016, focusing on life science investment with initial size of 600 million RMB. The Guangzhou Elim Biotech Industry Venture Capital Management Company, controlled by a group of prominent Israel professionals, is the management company of the Fund. It has currently operational offices both in Guangzhou, China and Tele Aviv, Israel.

More
PROJECT

Guangzhou InMode Ltd.

Guangzhou InMode Ltd. is a wholly owned subsidiary of Israel Invasix L...

More
NEWS

Guangzhou Liaison Office in Israel

More

Other important visits & delegations during Q1 2017

More

Guangzhou Annual Investment Conference:

More

Israeli Prime Minister Office's Director General visit to Guangzhou

More

GIBF Annual Meeting

More

Israeli Prime Minister visit to China

More

The 3rd Israel-China Biotech Workshop

More

The President of Israel Asia Chamber of Commerce Mr. Ran Cohen, The Consul-General of Israel in Guangzhou Mr.Nadav Coben and Minister-Counsellor Mr. Idit Shamir were visited to Bio-...

More

Participated in the 18th Guangzhou Convention of Overseas Chinese Scholars in Science and Technology

More

Participated in Israel-China Business Forum in Israel

More

Guangzhou Sino-Israel E-medicine Seminar & The 2nd China-Israel Biotech Workshop

More

Consultant Signing Ceremony for Guangzhou Sino-Israel Bio-industry Incubation Center

More

Guangzhou Sino-Israel Ophthalmic Innovation Center Seminar

More

Signing Ceremony for Guangzhou Sino-Israel Bio-industry Investment Fund

More

Contract Signing Ceremony for Guangzhou Elim Bio-industry Venture Capital Investment Co.,Ltd

More

The 1st Israel-China Biotech Workshop & Cooperation signing ceremony

More
TEAM

Dr. Yehoshua (Shuki) Gleitman

Chairman

●The Chief Scientist of the State of Israel.

●The Director General of the Ministry of Industry and Trade, the State of Israel.

●Senior consultant to the World Bank on national R&D policies.

●Consultant to many countries, including: Singapore, Korea, South-Africa, Serbia, Poland.

●Chairman of the US-Israel Industrial R&D Foundation.

●Joint chairman of the US-Israel Science and Technology Commission.

●Honorary Consul General of Singapore in Israel.


Avner Lushi

CEO

●Partner at Israel HealthCare Ventures (IHCV), a leading Israeli venture capital fund focused on investing in life sciences companies.

●In the last 10 years led/was involved in investing ~$180M in ~30 Israeli life sciences companies.

●Founder, Partner and CEO of Life Sciences Transaction Support Ltd. (LTS). LTS is a PriceWaterhouseCoopers (PWC) subsidiary, which provides investment banking and business development services to life science companies.

●Served in senior positions at the Prime Minister Office and the Supreme Court of the State of Israel.


Prof. Shlomo Noy, MD, Ph.D., MBA

Chief Medical Officer

●A world expert in healthcare management, healthcare R&D, clinical trials,

●Former Director General of Israel's largest medical center (Sheba Medical Center).

●VP of R&D of Sheba Medical Center, in charge of all Sheba's R&D activities. Possesses 30 years of experience in healthcare management and promoting R&D, technology transfer, clinical trials, IP, licensing, and commercialization on the national and international level (over 60 signed tech transfer and licensing deals).

●Head of the Rehabilitation Hospital and the Head of the Psycho-Geriatric Department at the Sheba Medical Center.

● A Professor of Medicine and Associate Dean at the Sackler School of Medicine of the Tel-Aviv University.


Dr. Carl Geng

Managing Director

●Holds significant experience in government relations and deep knowledge of international high-tech transfer and governmental development plans in China.

●Held senior positions within the Chinese administration, including at the International Department of the Ministry of Foreign Affairs. Served as a member of the Chinese delegation to the UN and as a Chinese representative to different global economic organizations such as IMF, World Bank, WTO, PECC (Pacific Economic Cooperation Council), and Asian Development Bank .

●Served at the International Scientific Exchange Foundation of China (ISEFC) as an Assistant Secretary General and Deputy Secretary General. In this position he initiated some innovative international projects for high-tech cooperation and commercialization, mainly in new energy, environment protection, biotech and new agriculture.


Prof. Avraham Karasik, MD

Chief Scientific Officer

●A world expert and an opinion leader in the fields of diabetes,

●A senior advisor of several large multinational pharmaceutical companies, including Bayer, Merck & Co, Novordisk, AstraZeneca, and Teva.

●Serves as the Chief Medical Underwriter of the largest insurance company in Israel (Clal); previously the Chief Medical Underwriter of Mi●gdal-Generally, with significant experience in health insurance.

●Leads and advises many medical device and biotechnology startups on the

●A Professor of Medicine at the Sackler School of Medicine of the Tel-Aviv University, and the Head of the Endocrine Institute in Israel's largest medical center (Sheba Medical Center).

●Founder and Chairman of the International Congress of Pre-Diabetes and the Metabolic Syndrome.

●Author and co-author of dozens of articles in important peer-reviewed journals.


PARTNER
CONTACT
Tel:86-20-89115542
Email:yilin@gibf.com
GZ office location:Guangzhou International Biological Island spiral 3 Road Standard Industrial Unit 3 Phase 1, 2nd Floor
Tel:+972-3-6476159
Israel office location:34 Ha’Barzel St., Tel-Aviv 6971052 Israel

Submit